Normal weight individuals who develop type 2 diabetes: the personal fat threshold.

  title={Normal weight individuals who develop type 2 diabetes: the personal fat threshold.},
  author={Roy Taylor and Rury R. Holman},
  journal={Clinical science},
  volume={128 7},
Type 2 diabetes (T2DM) is frequently regarded as a disease of obesity and its occurrence in individuals of normal body mass index (BMI) is often regarded as indicating a non-obesity-related subtype. [] Key Method To illustrate this concept, we present the distribution curve of BMI at diagnosis for the UKPDS cohort, together with a diagram explaining individual behaviour within the population. The concept of PFT is of practical benefit in explaining the onset of diabetes and its logical management to the non…

Figures from this paper

Type 2 diabetes prevalence in Pakistan: what is driving this? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of Pakistan

There are higher than expected rates of T2DM/prediabetes in Pakistani ethnicity normal BMI individuals and targeted screening of older individuals with historical lack of educational opportunity, with a family history of T 2DM even if of normal BMI may result in a significant benefit in the Pakistan population.

Associations of BMI, waist circumference, body fat, and skeletal muscle with type 2 diabetes in adults

Estimated BF% associates strongly with type 2 diabetes, suggesting a neglected aspect of aetiology within T2D, and simple measures with biological relevance, available from data collected in most health surveys, may be more useful than the purely statistical terms BMI.

Types of obesity and their impact on long-term outcomes in patients with cardiovascular disease

It is necessary to create a new classification that would improve the stratification of the risk of developing cardiovascular disease and death in people with obesity, based on the construction of statistical models.

Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications

The rising prevalence of obesity is reviewed and potential mechanisms underlying its association with various comorbidities and how these respond to treatment are discussed, with a particular focus on cardiometabolic disease, malignancy and mental health.

Calorie restriction and reversal of type 2 diabetes

  • Roy Taylor
  • Medicine
    Expert review of endocrinology & metabolism
  • 2016
Type 2 diabetes can now be understood as a state of excess fat in liver and pancreas, and remains reversible for at least 10 years in most individuals.

Metabolic surgery for the treatment of type 2 diabetes in patients with BMI lower than 35 kg/m2: Why caution is still needed

  • B. HalpernM. Mancini
  • Medicine
    Obesity reviews : an official journal of the International Association for the Study of Obesity
  • 2019
An overall view of the metabolic benefits of bariatric/metabolic surgery in patients with class 1 obesity is provided, the procedure against clinical treatment is compared, and the rationale for defending caution on recommending the procedure to less obese individuals is presented.

Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue

It appears that insulin resistance is not a primary defect but it develops secondarily to increased fat mass, which develops from a mismatch between the surplus caloric intake and the storage capacity of adipose tissue.

Insulin Resistance in Primary Dietary Care Practice. Review of the Evidence and a Proposal for Daily Use

The focus on management in dietitians’ practices will shift from body weight as a clinical endpoint to deep and sustainable IR suppression to strengthen the evidence for tailor made carbohydrate restriction in patients with insulin resistance and metabolic syndrome.

Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals

Fatty liver is an independent risk factor for progression from metabolically healthy status to metabolically abnormal phenotype, even in non-overweight individuals, after adjusting for age, sex, alcohol, smoking, exercise, impaired fasting glucose, hypertension, hypertriglyceridemia, low high density lipoprotein-cholesterol concentration, and abdominal obesity.



Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?

  • A. VaagS. Lund
  • Medicine, Biology
    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
  • 2007
Prevention of type 2 diabetes mellitus with lifestyle intervention is at least as effective in non-obese as in obese prediabetic subjects, and recent data suggest that metformin treatment targeting insulin resistance and non-glycemic cardiovascular disease risk factors is as beneficial in non/obese patients with T2DM.


The hypothesis that the majority of cases of type 2 diabetes could be prevented by the adoption of a healthier lifestyle is supported.

Diabetes incidence in Pima indians: contributions of obesity and parental diabetes.

In the Pimas, both obesity and diabetes have become more common during this century, perhaps as a result of rapid cultural and dietary changes in a population genetically susceptible to diabetes.

A Comparison of the Relative Effects of Obesity and Non-insulin-dependent Diabetes Mellitus on In Vivo Insulin-stimulated Glucose Utilization

The data emphasize the profound effect of NIDDM on reducing in vivo insulin action, and point out that the impact of obesity on insulin resistance is minor in comparison.

Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus

The present study demonstrated the long-term beneficial effect of metformin in non-obese (BMI < 25 kg/m2) diabetic patients and the observed worsening in glycemic control over time can probably be attenuated by increasing the dose of meetformin.

The impact of liver fat vs visceral fat in determining categories of prediabetes

Liver fat, more than visceral fat, strongly increases when glycaemia and glucose tolerance move from NGT to isolated IFG, isolated IGT and IFG+IGT, and it is worth searching for hepatokines more strongly predicting prediabetes categories.

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

Normalisation of both beta cell function and hepatic insulin sensitivity in type 2 diabetes was achieved by dietary energy restriction alone, and was associated with decreased pancreatic and liver triacylglycerol stores.

Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus

In obese NIDDM, weight loss results in improved glucose homeostasis with improved postprandial glucose excursions with marked amelioration of peripheral insulin resistance due to improved postreceptor insulin action, which is at least partly due to enhanced glucose transport system activity.

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

Data demonstrate that IHTG, not VAT, is a better marker of the metabolic derangements associated with obesity, and alterations in tissue fatty acid transport could be involved in the pathogenesis of ectopic triglyceride accumulation by redirecting plasma fatty acid uptake from adipose tissue toward other tissues.